Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel SYK inhibitor shows antitumor activity in preclinical models

Aug. 19, 2015

Novartis gives details on early testing of potent BCR-ABL allosteric inhibitor

Aug. 19, 2015

Discovery and optimization of novel HIV integrase inhibitors from BMS

Aug. 19, 2015

Merck & Co. describes discovery of novel DGAT2 inhibitors

Aug. 19, 2015

Novel alpha7 nACh receptor partial agonist shows potential for use in schizophrenia

Aug. 18, 2015

AstraZeneca positions antitumor compound AZD-4320 for clinical development

Aug. 18, 2015

A novel modified glycosaminoglycan shows efficacy for mouth disorders

Aug. 18, 2015

First inhalable prostacyclin IP receptor agonist for pulmonary arterial hypertension

Aug. 18, 2015

Vitae Pharmaceuticals gives details on discovery of LXRbeta agonist

Aug. 18, 2015

Merck & Co. discloses novel series of BACE1 inhibitors for AD

Aug. 17, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...